Tag: Baraclude

Bristol Myers Squibb (BMS) has announced an agreement with the US government aimed at improving access to Eliquis (apixaban), an oral anticoagulant used in the treatment and prevention of blood clots. Under the agreement, Eliquis will be provided to the Medicaid programme at no cost from 1 Jan 2026. As...